General Information of the Compound
| Compound ID |
CP0153516
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Anilino quinazoline deriv. 15
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3-Bromo-phenyl)-quinazolin-4-yl-amine
(3-bromophenyl)quinazolin-4-ylamine
4-Anilino quinazoline deriv. 15
4-Quinazolinamine, N-(3-bromophenyl)-
AC1LEF72
AKOS002264782
BDBM3264
CHEMBL290096
MCULE-4660970870
N-(3-Bromophenyl)-4-quinazolinamine
N-(3-bromophenyl)quinazolin-4-amine
SCHEMBL2992623
ZINC151213
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H10BrN3
|
||||||||||||||||||
| Molecular Weight |
300.159
|
||||||||||||||||||
| Canonical SMILES |
Brc1cccc(Nc2ncnc3ccccc23)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H10BrN3/c15-10-4-3-5-11(8-10)18-14-12-6-1-2-7-13(12)16-9-17-14/h1-9H,(H,16,17,18)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SUTRLYZWRGPLSJ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Protein ID: PT00922, Epidermal growth factor receptor
Clinical Information about the Compound